Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
MAGE-A4 IHC 1F9 pharmDx (SK032)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Agilent Tech
Type:
FDA Approved
Related tests:
‹
PD-L1 IHC 22C3 pharmDx (54)
HercepTest (7)
HER2 IQFISH pharmDx (5)
PD-L1 IHC 28-8 pharmDx (4)
Dako EGFR pharmDx™ (1)
Dako c-KIT pharmDx (1)
PD-L1 IHC 73-10 pharmDx (1)
Agilent SureSelect Cancer CGP Assay
BRCA MASTR Plus Dx
Claudin18.2 IHC 14G11 pharmDx
ER/PR pharmDx™ Kit
HER2 CISH pharmDx Kit
Ki-67 IHC MIB-1 pharmDx
TOP2A FISH pharmDx Kit
PD-L1 IHC 22C3 pharmDx (54)
HercepTest (7)
HER2 IQFISH pharmDx (5)
PD-L1 IHC 28-8 pharmDx (4)
Dako EGFR pharmDx™ (1)
Dako c-KIT pharmDx (1)
PD-L1 IHC 73-10 pharmDx (1)
Agilent SureSelect Cancer CGP Assay
BRCA MASTR Plus Dx
Claudin18.2 IHC 14G11 pharmDx
ER/PR pharmDx™ Kit
HER2 CISH pharmDx Kit
Ki-67 IHC MIB-1 pharmDx
TOP2A FISH pharmDx Kit
›
Details
Evidence
News
MAGE-A4 IHC 1F9 pharmDx is an immunohistochemistry (IHC) assay used to detect MAGE-A4 expression in formalin-fixed paraffin-embedded (FFPE) synovial sarcoma tissue. MAGE-A4 IHC 1F9 pharmDx is the first IVD for MAGE-A4 available on the market.
Cancer:
Synovial Sarcoma
Gene:
MAGEA4 (Melanoma antigen family A, 4)
MAGEA4 (Melanoma antigen family A, 4)
Method:
Immunohistochemistry (IHC)
Approvals
Date
Cancer
Gene
Biomarker
Drug
Approved by
08/02/2024
Synovial Sarcoma
MAGEA4
-
FDA Approved
Approvals
Date
Cancer
Gene
Drug
By
08/02/24
SS
MAGEA4
FDA
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login